C

Contineum Therapeutics Inc
NASDAQ:CTNM

Watchlist Manager
Contineum Therapeutics Inc
NASDAQ:CTNM
Watchlist
Price: 12.26 USD -6.2%
Market Cap: 357.7m USD

Wall Street
Price Targets

CTNM Price Targets Summary
Contineum Therapeutics Inc

Wall Street analysts forecast CTNM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTNM is 22.44 USD with a low forecast of 14.14 USD and a high forecast of 30.45 USD.

Lowest
Price Target
14.14 USD
15% Upside
Average
Price Target
22.44 USD
83% Upside
Highest
Price Target
30.45 USD
148% Upside
Contineum Therapeutics Inc Competitors:
Price Targets
JOMA
John Mattson Fastighetsforetagen publ AB
12% Upside
ABP
Azienda Bresciana Petroli Nocivelli SpA
23% Upside
EAST
Eastnine AB (publ)
27% Upside
CORAZA
Coraza Integrated Technology Bhd
35% Upside
WHART
WHA Premium Growth Freehold and Leasehold Real Estate Investment Trust
14% Upside
IMPACT
IMPACT Growth Real Estate Investment Trust
17% Upside

Revenue
Forecast

Revenue Estimate
Contineum Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Contineum Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Contineum Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CTNM's stock price target?
Price Target
22.44 USD

According to Wall Street analysts, the average 1-year price target for CTNM is 22.44 USD with a low forecast of 14.14 USD and a high forecast of 30.45 USD.

Back to Top